Deadline 2015/06/01 - ASRM CMC In-training Travel Awards

The American Society for Reproductive Medicine is pleased to announce the availability of a limited number of awards to support the travel of trainees who are presenting abstracts at the 2015 Annual Meeting in Baltimore. These awards are made possible through the generous support of the ASRM Board of Directors and the ASRM Corporate Member Council.  

Congratulations to the 2014 Award Winners:

O-4  - REDUCTION OF PRO-INFLAMMATORY CYTOKINES IS ASSOCIATED WITH IMPROVEMENT OF GONADOTROPIN SENSITIVITY IN OBESE WOMEN. Z. A. Al-Safi, J. Chosich, K. Berenbaum, A. Bradford, N. Santoro, A. J. Polotsky. University of Colorado, Aurora, CO.

O-15  - GNRH AGONIST WITH LOW-DOSE HCG CO-TRIGGER IS ASSOCIATED WITH HIGHER RISK OF SEVERE OHSS THAN GNRH AGONIST ALONE. K. O’Neill, S. Senapati, I. Maina, C. Gracia, A. Dokras. Department of Obstetrics & Gynecology, University of Pennsylvania, Philadelphia, PA.

O-110 - SPECIAL RESEARCH PRESENTATION: MOLECULAR SIGNATURES OF FIBROID STEM CELLS (SCS) IMPLICATE IGF2 AS A POTENTIAL NEW TARGET. M. B. Moravek, P. Yin, M. Ono, V. Vidimar, J. Kim, S. E. Bulun. Northwestern University, Chicago, IL.

O-111 - THE POWER OF SWEAT: VIGOROUS EXERCISE IS ASSOCIATED WITH IMPROVED OUTCOMES IN POLYCYSTIC OVARIAN SYNDROME (PCOS) INDEPENDENT OF TOTAL EXERCISE VOLUME. E. A. Greenwood, L. A. Pasch, K. Shinkai, M. I. Cedars, H. G. Huddleston. OB/Gyn, UCSF, San Francisco, CA.

O-113 - SPHINGOSINE-1-PHOSPHATE, A PROTECTOR AGAINST CHEMOTHERAPY-INDUCED OVARIAN FOLLICLE APOPTOSIS, DOES NOT DIMINISH THE EFFECTIVENESS OF CHEMOTHERAPY. S. Titus1,2, R. Stobezki1, V. Turan1,2, D. Halicka1, P. De Sutter3, K. Oktay1,2. 1New York Medical College, Valhalla, NY; 2Innovation Institute for Fertility Preservation and IVF, New York, NY; 3Gent University, Gent, Belgium. 

O-115 - CHARACTERIZATION OF ADRENAL ANDROGEN PRODUCTION IN FUNCTIONALLY DISTINCT WOMEN WITH POLYCYSTIC OVARY SYNDROME. K. H. Maas, E. Harrison, S. Chuan, H. Cook-Andersen, A. Duleba, R. J. Chang. Dept. of Repro. Med., UCSD, La Jolla, CA.

O-116 - TIME-TO-PREGNANCY AND SECONDARY SEX RATIO IN A PRECONCEPTION COHORT. K. J. Sapra, J. Bae, S. Kim, G. M. Buck Louis. pision of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health & Human Development, Rockville, MD.

O-122 - IMPORT AND EXPORT OF FROZEN DONOR OOCYTE BANK: DOES TRANSPORTATION AFFECT SURVIVAL AND PREGNANCY RATES? J. M. Cox1, K. Fru1, J. Lim2, T. Earl3, H. Hayes3, K. S. Richter2, B. Kaplan4, J. Frattarelli5, A. DeCherney1, M. Levy2. 1PRAE, NICHD, NIH, Bethesda, MD; 2Shady Grove Fertility, Rockville, MD; 3Donor Egg Bank USA, Rockville, MD; 4Fertility Centers of Illinois, Chicago, IL; 5Fertility Institute of Hawaii, Honolulu, HI. 

O-132 - GAPS BETWEEN PHYSICIANS’ PERCEPTIONS OF THE IMPORTANCE OF SHARED DECISION MAKING AND THEIR PRACTICE IN MENOPAUSAL SYMPTOM MANAGEMENT. S. Kiatpongsan1,2,3, S. Feibelmann3, K. Sepucha3,4. 1Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 2Harvard Interfaculty Initiative in Health Policy, Cambridge, MA; 3Massachusetts General Hospital, Boston, MA; 4Harvard Medical School, Boston, MA.

O-218 - SURGICAL PAIN CONTROL WITH ROPIVACAINE BY ATOMIZED DELIVERY (SPRAY): A RANDOMIZED CONTROLLED TRIAL. G. G. Collins, J. Gadzinski, G. Fitzgerald, J. Sheran, S. Wagner, E. Mueller. Obstetrics & Gynecology, Loyola University Medical Center, Maywood, IL.

O-228 - SYSTEMIC AND FOLLICULAR OXIDATIVE STRESS IN INFERTILE WOMEN WITH ENDOMETRIOSIS UNDERGOING CONTROLLED OVARIAN STIMULATION FOR ICSI: IS THERE A ROLE IN THE ETIOPATHOGENESIS OF INFERTILITY? M. G. Da Broi1, F. O. Albuquerque1, A. Z. de Andrade1, R. L. Cardoso1, A. A. Jordão Jr2, P. A. Navarro1. 1Department of Obstetrics and Gynecology, Human Reproduction pision, Faculty of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil; 2Nutrition and Metabolism Laboratory, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, Sao Paulo, Brazil.

O-314 - RISK FACTORS FOR SEXUAL DYSFUNCTION IN BRCA1 AND BRCA2 (B1/2) MUTATION CARRIERS FOLLOWING RISK-REDUCING  SALPINGOOOPHORECTOMY (RRSO). J. L. Chan, S. Senapati, L. N. C. Johnson, L. DiGiovanni, C. Voong, S. F. Butts, S. M. Domchek. University of Pennsylvania, Philadelphia, PA. 

P-48 - INTRACAVITARY VAGINAL BRACHYTHERAPY IN EARLY STAGE ENDOMETRIAL CARCINOMA - IMPACT ON SEXUAL FUNCTION. C. Singh. Department of Radiotherapy and Clinical Oncology, S.M.S Medical College and Hospital, Jaipur, Rajasthan, India.

P-276 - BLASTOCYST COLLAPSING AND SUBSEQUENT DISSECTION OF [frac14] OF ZONA PELLUCIDA BEFORE THE EMBRYOTRANSFER SIGNIFICANTLY INCREASE PREGNANCY RATE IN FRESH CYCLES. Y. Lesniak1,2, O. Chaplia1, G. Botsiura1, N. Melnyk1. 1Embryology Department, Reproductive Genetics Clinic ‘Victoria’, Kyiv, Kyivska Oblast, Ukraine; 2Department of Molecular Diagnostics Studies, National University of Life and Environmental Sciences of Ukraine, Kyiv, Kyivska Oblast, Ukraine.

P-587 - OOCYTES FROM WOMEN WITH DIMINISHED OVARIAN RESERVE AND OBESITY HAVE SHORTENED TELOMERES. D. M. F. Antunes1,2, K. K. Kalmbach1, F. Wang1, M. L. Seth-Smith1, Y. Kramer1, F. B. Kohlrausch2, D. L. Keefe1. 1Department of Obstetrics and Gynecology, New York University, New York, NY; 2Department of Pathology, Fluminense Federal University, Niteroi, Rio de Janeiro, Brazil.

 

ASRM MEMBERSHIP

View Details
Learn More | Join | Renew
Back to Top